Status:

COMPLETED

De-escalated Conformal Radiation Expedited Sequentially With Chemotherapy for Endometrial Cancer

Lead Sponsor:

Washington University School of Medicine

Conditions:

Endometrial Cancer

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The goal of this study is to evaluate short course radiation in the post-operative female pelvis after hysterectomy in stage III-IVA endometrial adenocarcinoma patients, or any stage patients with ute...

Eligibility Criteria

Inclusion

  • Histologically or cytologically confirmed stage IIIA-IVA endometrial cancer, or any stage I-IVA where any proportion of the tumor is uterine serous, clear cell, de-differentiated, or carcinosarcoma histology.
  • Must have already undergone radical hysterectomy. Hysterectomy may have occurred no more than one year prior to enrollment.
  • At least 18 years of age.
  • ECOG performance status ≤ 2
  • Minimal bone marrow and organ function as defined below:
  • Leukocytes ≥ 1,000 cumm
  • Absolute neutrophil count ≥ 500 cumm
  • Platelets ≥ 50,000 cumm
  • Hemoglobin ≥ 7g/dL
  • Ability to understand and willingness to sign an IRB approved written informed consent document (or that of legally authorized representative, if applicable).

Exclusion

  • Prior radiation to the pelvis.
  • Currently receiving any investigational agents.
  • Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, inflammatory bowel disease, or irritable bowel disease.
  • Patients with HIV are eligible unless their CD4+ T-cell counts are \< 350 cells/mcL or they have a history of AIDS-defining opportunistic infection within the 12 months prior to registration. Concurrent treatment with effective ART according to DHHS treatment guidelines is recommended.

Key Trial Info

Start Date :

July 7 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 13 2025

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT04386993

Start Date

July 7 2020

End Date

October 13 2025

Last Update

October 20 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Washington University School of Medicine

St Louis, Missouri, United States, 63110